Zanos Lab awarded €20,000 grant by the A. G. Leventis Foundation for our ongoing research on rapid-acting antidepressants.

We are excited to announce that the Zanos Lab has just been awarded a grant of €20,000 by the A.G. Leventis Foundation. This funding will significantly enhance our ongoing research efforts to uncover the mechanisms of action behind rapid-acting antidepressant compounds.

Depression remains one of the most challenging mental health conditions, and the discovery of rapid-acting antidepressants has opened new avenues for treatment. Our lab is dedicated to understanding how these compounds work at a molecular level, which could pave the way for more effective therapies for those suffering from depression.

The support from the A.G. Leventis Foundation will allow us to advance our studies, contributing valuable insights to the scientific community and offering hope to millions affected by this debilitating condition.

We look forward to sharing our findings with the community as we continue our mission to make a meaningful impact in the field of mental health.